Cornell researchers received a $500,000 grant from the Centers for Disease Control and Prevention to help in a national initiative to combat drug-resistant organisms, sometimes referred to as "superbugs."
New research by Weill Cornell Medicine shows chemotherapy kills the most common type of bladder cancer, urothelial cancer, but it also shapes genetic evolution of remaining urothelial cancer cells.
Two Weill Cornell Medicine faculty members, Dr. Francis Lee and Dr. Jane Salmon, were elected to National Academy of Medicine, it was announced Oct. 17.
An overactive gene appears to cause some prostate cancers to transform from a typical tumor type to a much more aggressive form of the disease, according to new research at Weill Cornell Medicine.
A deep-freezing technique known as cryoablation is a viable alternative to traditional surgery in many early-stage breast cancers according to Weill Cornell Medicine research.
Research involving cancer-targeting silica particles, known as Cornell dots, has shown that the particles can neutralize nutrient-deprived cancer cells by a cell-death process called ferroptosis.
An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease.
New research by Weill Cornell Medicine investigators could offer researchers a new scientific avenue to pursue treatments for X-linked chromosomal diseases in females such as Rett syndrome.
